Earnings Feed
Start Free
Tonix Pharmaceuticals Holding Corp.·4

Jul 1, 4:05 PM ET

LEDERMAN SETH 4

4 · Tonix Pharmaceuticals Holding Corp. · Filed Jul 1, 2022

Insider Transaction Report

Form 4
Period: 2022-06-29
Tonix Pharmaceuticals Holding Corp.TNXP
LEDERMAN SETH
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock, $0.001 par value

    2022-06-29$1.71/sh+20,000$34,200→ 24,235 total(indirect: By IRA)
Holdings

  • Common Stock, $0.001 par value

    (indirect: By Leder Laboratories, Inc.)
    1

  • Common Stock, $0.001 par value

    (indirect: By LLC)
    2

  • Common Stock, $0.001 par value

    (indirect: By LLC)
    7

  • Common Stock, $0.001 par value

    (indirect: By LLC)
    2

  • Common Stock, $0.001 par value

    (indirect: By Spouse)
    1

  • Common Stock, $0.001 par value

    3,505

  • Common Stock, $0.001 par value

    (indirect: By Starling Pharmaceuticals, Inc.)
    1
Footnotes (2)
  • [F1]Shares reported reflect a 1-for-32 reverse stock split effective May 17, 2022.
  • [F2]Reporting person may be deemed to be a control person of this entity.

Documents

1 file
  • 4
    lederman-form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP